| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.73B | 50.98B | 47.47B | 36.70B | 32.41B | 26.29B |
| Gross Profit | 39.81B | 46.84B | 46.33B | 33.72B | 31.74B | 23.10B |
| EBITDA | 14.12B | 22.12B | 20.14B | 9.90B | 7.05B | 5.93B |
| Net Income | 10.29B | 15.05B | 13.35B | 5.28B | 4.20B | 3.49B |
Balance Sheet | ||||||
| Total Assets | 1.61T | 1.70T | 1.59T | 1.58T | 1.49T | 1.47T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 83.58B | 80.71B | 68.64B | 74.90B | 55.07B |
| Total Debt | 10.08B | 25.86B | 19.81B | 53.18B | 23.96B | 63.41B |
| Total Liabilities | 1.45T | 1.50T | 1.44T | 1.42T | 1.36T | 1.35T |
| Stockholders Equity | 158.60B | 198.57B | 152.52B | 148.68B | 115.12B | 114.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.72B | 4.71B | 7.21B | -24.09B | -4.79B |
| Operating Cash Flow | 0.00 | 4.04B | 5.66B | 8.20B | -23.70B | -4.27B |
| Investing Cash Flow | 0.00 | -46.36B | 11.18B | -12.51B | 46.04B | -14.57B |
| Financing Cash Flow | 0.00 | 42.67B | -2.59B | -2.04B | -1.98B | -800.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥178.84B | 12.13 | ― | 2.96% | 21.41% | 42.73% | |
70 Outperform | ¥176.12B | 13.36 | 3.68% | 2.26% | 23.47% | 44.30% | |
68 Neutral | ¥171.80B | 8.14 | ― | 2.63% | 5.33% | 14.43% | |
68 Neutral | ¥190.90B | 15.92 | ― | 2.56% | 42.06% | 29.62% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥174.83B | 10.12 | ― | 2.29% | 9.41% | 45.91% | |
58 Neutral | ¥11.40B | 11.28 | ― | 2.68% | 24.95% | 10.64% |